12:00 AM
 | 
Jul 16, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Dificid fidaxomicin regulatory update

The U.K.'s NICE published a summary of clinical evidence for antibiotic Dificlir fidaxomicin to treat Clostridium difficile infection (CDI) - its approved indication. The report is the first under the committee's new program to publish summaries about selected new medicines that would not otherwise be subject to a complete cost- and clinical effectiveness appraisal. The summaries do not constitute formal NICE guidances....

Read the full 299 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >